You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Boehringer Ingelheim
McKinsey
McKesson
Dow

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-03-03
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand None Referred To
Parties NOVO NORDISK A/S; NOVO NORDISK INC.; TEVA PHARMACEUTICALS USA, INC.
Patents 6,235,004; 6,268,343; 8,114,833; 8,846,618; 9,265,893; RE41,956
Attorneys Brian P. Egan; Gregory Springsted; Jack B. Blumenfeld; Karen Elizabeth Keller; Leora Ben-Ami; Maryellen Noreika; Robert Hyberg; Thomas F. Fleming
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-06-26 61 Report and Recommendations ., 1:24-26 ("U.S. Pat. No. 6,235,004 [("the '004 patent")] discloses an injection device….S. Patent Nos. 6,268,343 ("the '343 patent"); 8,114,833 ("the '833 patent"…(EP '581 patent at 17), as do similar figures in the '004 patent, '004 patent, figs. 15-16…the '004 patent. '893 patent, 1:29-34 (citing Figs. 15-16 of the '004 patent) ("[T]he….S. Patent Nos. 8,114,833 ("the '833 patent"); 9,265,893 ("the '893 patent" External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Mallinckrodt
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.